α7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues

被引:25
作者
Briggs, C. A. [1 ]
Schrimpf, M. R. [1 ]
Anderson, D. J. [1 ]
Gubbins, E. J. [1 ]
Gronlien, J. H. [1 ]
Hakerud, M. [1 ]
Ween, H. [1 ]
Thorin-Hagene, K. [1 ]
Malysz, J. [1 ]
Li, J. [1 ]
Bunnelle, W. H. [1 ]
Gopalakrishnan, M. [1 ]
Meyer, M. D. [1 ]
机构
[1] Abbott Labs, Neurosci Res, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
关键词
nicotinic acetylcholine receptor; alpha 7 nicotinic receptor; Xenopus oocytes; cognition; tilorone;
D O I
10.1038/sj.bjp.0707649
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: The alpha 7 nicotinic acetylcholine receptor ( nAChR) has attracted considerable interest as a target for cognitive enhancement in schizophrenia and Alzheimer's Disease. However, most recently described alpha 7 agonists are derived from the quinuclidine structural class. Alternatively, the present study identifies tilorone as a novel alpha 7-selective agonist and characterizes analogues developed from this lead. Experimental approach: Activity and selectivity were determined from rat brain alpha 7 and alpha 4 beta 2 nAChR binding, recombinant nAChR activation, and native alpha 7 nAChR mediated stimulation of ERK1/2 phosphorylation in PC12 cells. Key results: Tilorone bound alpha 7 nAChR (IC50 110 nM) with high selectivity relative to alpha 4 beta 2 ( IC50 70 000 nM), activated human alpha 7 nAChR with an EC50 value of 2.5 mu M and maximal response of 67% relative to acetylcholine, and showed little agonist effect at human alpha 3 beta 4 or alpha 4 beta 2 nAChRs. However, the rat alpha 7 nAChR maximal response was only 34%. Lead optimization led to 2-(5-methyl-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl)-xanthen-9-one(A-844606) with improved binding (alpha 7 IC50 11 nM, alpha 4 beta 2 IC50 > 30000 nM) and activity at both human and rat alpha 7 nAChR (EC(50)s 1.4 and 2.2 mu M and apparent efficacies 61 and 63%, respectively). These compounds also activated native alpha 7 nAChR, stimulating ERK1/2 phosphorylation in PC12 cells. Conclusions and implications: Tilorone, known as an interferon inducer, is a selective alpha 7 nAChR agonist, suggesting utility of the fluorenone pharmacophore for the development of alpha 7 nAChR selective agonists. Whether alpha 7 stimulation mediates interferon induction, or whether interferon induction may influence the potential anti-inflammatory properties of alpha 7 nAChR agonists remains to be elucidated.
引用
收藏
页码:1054 / 1061
页数:8
相关论文
共 52 条
[51]   Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the α7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia:: Synthesis and structure-activity relationship [J].
Wishka, Donn G. ;
Walker, Daniel P. ;
Yates, Karen M. ;
Reitz, Steven C. ;
Jia, Shaojuan ;
Myers, Jason K. ;
Olson, Kirk L. ;
Jacobsen, E. Jon ;
Wolfe, Mark L. ;
Groppi, Vincent E. ;
Hanchar, Alexander J. ;
Thornburgh, Bruce A. ;
Cortes-Burgos, Luz A. ;
Wong, Erik H. F. ;
Staton, Brian A. ;
Raub, Thomas J. ;
Higdon, Nicole R. ;
Wall, Theron M. ;
Hurst, Raymond S. ;
Walters, Rodney R. ;
Hoffmann, William E. ;
Hajos, Mihaly ;
Franklin, Stanley ;
Carey, Galen ;
Gold, Lisa H. ;
Cook, Karen K. ;
Sands, Steven B. ;
Zhao, Sabrina X. ;
Soglia, John R. ;
Kalgutkar, Amit S. ;
Arneric, Stephen P. ;
Rogers, Bruce N. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) :4425-4436
[52]   Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice [J].
Young, Jared W. ;
Crawford, Nicola ;
Kelly, John S. ;
Kerr, Lorraine E. ;
Marston, Hugh M. ;
Spratt, Christopher ;
Finlayson, Keith ;
Sharkey, John .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (02) :145-155